AVCRFPharmaceutical PreparationsFiscal year ends December 31

Avricore Health Inc.

Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Jun 16, 2025

$0.00+0.00 (0.00%)

Close on Oct 16, 2026

Fundamental chart

Pick a measure to chart its full history

C$4.66MFY2024, +244.6% a year since FY2020

Parsed from the XBRL in Avricore Health's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-4 reverse split on Nov 21, 2016
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is AVCRF.

Revenue growth33.7% · median 137.6%

Advertisement
300 × 250